Haw Par Corporation Limited H02
SGX · Singapore · Health Technology
SGD 13.09+0.03 (+0.23%)
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Key Insights The considerable ownership by private companies in Haw Par indicates that they collectively have a greater...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.